Yale Cancer Center researchers receive Kidney Cancer Association grants

Yale Cancer Center researchers receive Kidney Cancer Association grants

David Braun, MD, PhD, assistant professor of medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, and Nazli Dizman, MD, resident in internal medicine at Yale School of Medicine, both received Trailblazer Awards from the Kidney Cancer Association. The awards support researchers pursuing projects that may improve kidney cancer treatment and care.

Dr. Braun cares for patients with kidney cancer and his research focuses on the integration of experimental and computational approaches to biomedical research. He is also a member of the Yale Center for Molecular and Cellular Oncology. His project is titled “Dissecting the immunobiology of chromophobe renal cell carcinoma using single-cell transcriptomics”.

Dr. Dizman’s research focuses on molecular targeted therapy, drug-related side effects and adverse events, and the gastrointestinal microbiome. Dr. Dizman recently conducted a study evaluating the impact of dietary interventions on the gut microbiome in patients with metastatic renal cell carcinoma receiving immunotherapies. His current project is titled “Impact of CBM588 on the metabolomic profile in patients with metastatic renal cell carcinoma (mRCC)”.

The Trailblazer Award is a new award category from the Kidney Cancer Association this year and funds promising early career investigators to foster innovative kidney cancer research. The Kidney Cancer Association is a global community dedicated to serving and empowering patients and caregivers, and driving change through advocacy, research and education in order to be the universal leader in the search for the cure. against kidney cancer.

Submitted by Emily Montemerlo on September 22, 2022

#Yale #Cancer #Center #researchers #receive #Kidney #Cancer #Association #grants

Leave a Comment

Your email address will not be published.